Health authorities in three Canadian provinces have raised concerns about a rare bacterial infection causing meningitis and fatalities. Ontario and Manitoba have seen a recent uptick in cases, with Toronto reporting 13 cases in 2024, exceeding the yearly average since 2002.
Public health experts emphasize the rapid onset of symptoms, urging prompt medical attention. The disease, known as invasive meningococcal disease (IMD), can be deadly, with survivors often experiencing severe complications. Earlier alerts were issued in Manitoba, Kingston, and Quebec.
While the National Microbiology Laboratory reports increased activity in Ontario and Manitoba, overall national cases have remained steady. In the U.S., over 140 cases have been recorded in 2024. The disease, prevalent in sub-Saharan Africa's "meningitis belt," underscores the importance of vaccination, especially for travelers and those attending mass gatherings.
Symptoms include headache, fever, and a dark rash, requiring immediate medical care. Vaccination is crucial for prevention, with free doses offered to children and teens. The disease predominantly affects children under five and unvaccinated individuals. Health authorities stress hygiene practices to prevent transmission.
The Public Health Agency of Canada is actively monitoring the situation, collaborating with federal, provincial, and local partners to ensure public safety. Individuals experiencing symptoms are urged to seek urgent medical attention.